Latest Interviews
Showing 1–5 of 5 transcripts.
Clear all filters- a16z59 min
The 2045 Superintelligence Timeline: Epoch AI’s Data-Driven Forecast
Yafah Edelman, David Owen, Marco Mascorro, Erik Torenberg, Kirsten, Jeff
Speakers analyze current AI spending as a signal of immediate value rather than a bubble, noting that while rapid compute growth and data center scaling are underway, future profitability hinges on whether large model investments yield proportional returns. The discussion forecasts rapid economic integration with potential GDP gains of 30% under AGI scenarios, alongside a 20-30% risk of a sudden unemployment spike that could trigger immediate government intervention. Looking toward technical milestones, the event projects significant breakthroughs in mathematical problem-solving and robotics within five years, while warning that traditional benchmarks will soon saturate as the industry shifts toward measuring real-world system performance.
- Y Combinator59 min
Suhail Doshi - How to Measure Your Product
Suhail Doshi, Gustav, Jeff, Andrew Chen, Stuart, Robbie Walker, PG, Adora
Mixpanel co-founder Suhail Doshi outlined a strategic framework for product measurement focused on solving understanding, onboarding, and retention while warning against the complexity that causes decision paralysis. He detailed a five-lever growth formula and the critical importance of selecting a single North Star Metric, citing Mixpanel's own pivot from generic analytics to engagement tracking as a model for differentiation. The presentation concluded by advocating for harsh retention benchmarks and daily active user metrics to avoid the "Shark Fin" growth pattern, emphasizing that sustainable growth requires prioritizing fundamental user activation over immediate feature expansion.
- Y Combinator58 min
Paul Buchheit - Startup Investor School Day 2
Startup investor Paul Buchheit outlines a strategy prioritizing founders with impossibly ambitious visions and demonstrated resilience over those with polished metrics or low valuations. His approach is validated by massive returns from diverse ventures like Meraki, Twitch, and Cruise, which emerged from ideas that initially appeared flawed or "stupid" to outsiders. Conversely, Buchheit warns that "value investing," pity funding, and slow decision-making consistently lead to losses by missing top-tier opportunities like Airbnb or falling for over-funded failures like Juicero.
- Y Combinator59 min
Carolynn Levy and Kirsty Nathoo - Startup Investor School Day 1
Carolynn Levy, Kirsty Nathoo, Jeff, Sam
The Simple Agreement for Future Equity (SAFE) is a non-debt convertible security designed for early-stage startups to facilitate rapid fundraising through a streamlined five-page document governed by valuation caps or discount rates. While lacking traditional creditor rights like interest or repayment, the instrument converts into preferred stock during priced rounds or liquidity events, with investor returns determined by complex pre-money conversion mechanics and pro rata participation rights. Best practices for execution involve rapid e-signature processing via platforms like Clerky and strict adherence to Y Combinator's handshake protocols to secure high upside potential while avoiding unnecessary legal complexity.
- Milken Institute1h 15m
The Promise of the Bioscience Century
Paul Irving, Mike Milken, Eric Cantor, Paul Chu, Jeff, Bernardo Zavala, Jr., Bernard Harris, Andy von Eschenbach, Peggy, Francis Collins, Chris Austin
This event analyzes the critical role of bioscience in driving global economic growth and societal well-being while highlighting China's aggressive $308 billion investment program that threatens to surpass U.S. leadership. Panelists discuss strategic institutional responses, such as DARPA's high-risk research model and the FDA's regulatory innovations, which have accelerated breakthroughs in prosthetics, personalized medicine, and disease prevention. However, fiscal constraints and shifting global demographics necessitate sustained bipartisan funding to preserve the United States' status as a central hub for scientific innovation and global health security.